Tarja Lamminen - UTU Research Portal

Tarja Lamminen

tarlammi@utu.fi

Kiinamyllynkatu 10

Turku

2 of 2

Chemical biology approach to phenotypic intratumor heterogeneity as a source of chemotherapy resistance in high-grade serous ovarian cancer (2018)
- Clinical Cancer Research
Bulanova DR, Kaipio K, Lamminen T, Ianevski A, Aittokallio T, Carpen O, Wennerberg K
High-throughput screening of new potential targets for high-grade serous ovarian cancer treatment (2018)
- Clinical Cancer Research
Dai J, Erkan EP, Zhang KY, Kaipio K, Lamminen T, Huhtinen K, Hynninen J, Grenman S, Carpen OM, Hautaniemi S, Vaharautio A
FHOD1 formin is upregulated in melanomas and modifies proliferation and tumor growth (2017)
- Experimental Cell Research
Peippo Minna, Gardberg Maria, Lamminen Tarja, Kaipio Katja, Carpen Olli, Heuser Vanina D.
In vivo mouse model for analysis of hydroxysteroid (17beta) dehydrogenase 1 inhibitors (2009)
- Molecular and Cellular Endocrinology
Lamminen T, Saloniemi T, Huhtinen K, Koskimies P, Messinger J, Husen B, Thole H, Poutanen M
Activation of androgens by hydroxysteroid (17beta) dehydrogenase 1 in vivo as a cause of prenatal masculinization and ovarian benign serous cystadenomas (2007)
- Molecular Endocrinology -Baltimore-
Saloniemi T, Lamminen T, Huhtinen K, Welsh M, Saunders P, Kujari H, Poutanen M